Search results
Results from the WOW.Com Content Network
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease , ulcerative colitis , rheumatoid arthritis , ankylosing spondylitis , psoriasis , psoriatic arthritis , and Behçet's disease . [ 23 ]
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from France's ...
Why haven't Remicade sales. he first rule of investing in pharmaceuticals is that when a drug loses patent protection, the drug maker loses sales. Remsima, a biosimilar version of Remicade, has ...
Remicade 5908 7152 14 Pneumococcal conjugate vaccine: Prevnar 13 Prevenar 13 ... ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012
infliximab-axxq/Avsola: infliximab/Remicade June 2020 [169] pegfilgrastim-apgf/Nyvepria: pegfilgrastim/Neulasta July 2020 [170] adalimumab-fkjp/Hulio: adalimumab/Humira December 2020 [171] rituximab-arrx/Riabni: rituximab/Rituxan July 2021 [172] insulin glargine-yfgn/Semglee: insulin glargine/Lantus September 2021 [173] ranibizumab-nuna/Byooviz ...
The 15 drugs accounted for $41 billion, or 14%, of total Medicare Part D spending between Nov. 1, 2023, and Oct. 1, 2024.
For premium support please call: 800-290-4726 more ways to reach us
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] As one of the world's largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022.